TCM
AZN icon

Traub Capital Management’s AstraZeneca AZN Stock Holding History

Traub Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390K Hold
2,058
– – 0.35% 75
2026
Q1 		$406K Hold
2,058
– – 0.4% 68
2025
Q4 		$378K Hold
2,058
– – 0.36% 72
2025
Q3 		$316K Buy
2,058
+65
+3% +$9.84K 0.31% 80
2025
Q2 		$278K Buy
+1,993
New +$279K 0.26% 83

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Traub Capital Management's AZN Position: Q2 2026 in Review

Traub Capital Management held its AstraZeneca (AZN) position steady in Q2 2026 at 2,058 shares worth $390K. The position accounts for 0.35% of the portfolio, ranked #75.

Traub Capital Management first reported a position in AZN in Q2 2025 and has held it in 5 quarters since. The position peaked at $406K in Q1 2026. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Traub Capital Management held 2,058 shares of AstraZeneca worth $390K as of Q2 2026.
  • Traub Capital Management left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.35% of Traub Capital Management's portfolio in Q2 2026, its #75 holding.
  • Traub Capital Management first reported a position in AstraZeneca in Q2 2025 and has held it in 5 quarters since.
  • Traub Capital Management's AstraZeneca position peaked at $406K in Q1 2026.
  • 443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Traub Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.